Literature DB >> 6319516

Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.

J Nussberger, D B Brunner, B Waeber, H R Brunner.   

Abstract

Current radioimmunoassays do not demonstrate total absence of angiotensin II during converting enzyme inhibition. To assess the meaning of plasma angiotensin II determinations during converting enzyme inhibition, plasma angiotensin I and II levels of normotensive humans during maximal converting enzyme inhibition by single oral doses of CGS 13945, MK 421, or MK 521 were compared with those of anephric rats (18 hr after nephrectomy) after intravenous administration of MK 422 (1 mg/kg). Prior to radioimmunoassay, plasma was extracted with Dowex for angiotensin II and blood extracted with ethanol for angiotensin I. During converting enzyme inhibition, in the 20 normotensive subjects plasma angiotensin II was 6.3 +/- 2.3 pg/ml (mean +/- S.D.) and blood angiotensin I was 65 +/- 59 pg/ml. In the nephrectomized rats, plasma angiotensin II was 8.9 +/- 2.3 pg/ml without converting enzyme inhibitor (n = 15) and 7.6 +/- 2.8 with MK 422 (n = 14), and blood angiotensin I was 9.8 +/- 2.4 pg/ml and 8.2 +/- 0.7, respectively. Dowex extraction of Tris buffer containing no angiotensin II provided blank values ranging from 5.0 to 7.8 pg/ml (n = 5). Thus plasma angiotensin II of normotensive humans treated with converting enzyme inhibitors fell to blank levels even in the presence of markedly elevated plasma angiotensin I. Angiotensin II concentrations in anephric rats with or without converting enzyme inhibition were the same. We therefore conclude that plasma levels of angiotensin II below 8 pg/ml measured after Dowex extraction probably reflect complete converting enzyme inhibition and virtual absence of angiotensin II generation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319516

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  4 in total

1.  Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.

Authors:  G Waeber; T Fasanella d'Amore; J Nussberger; B Waeber; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers.

Authors:  J P Bussien; J Nussberger; M Porchet; B Waeber; H R Brunner; M Perisic; M J Tansey; M Bomm; P Hajdu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-03       Impact factor: 3.000

3.  Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers.

Authors:  M D Schaller; J Nussberger; B Waeber; J P Bussien; G A Turini; H Brunner; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.

Authors:  M Burnier; V Mooser; J Nussberger; B Waeber; H R Brunner
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.